Genetic ‘Spelling mistakes’ that increase the risk of common cancers
More than 80 genetic ‘spelling mistakes’ that can increase the risk of breast, prostate and ovarian cancer have been found […]
News
Custodians of Cancer Care
D S Negi, CEO of RGCI Combination of technology and humane touch, sums up Rajiv Gandhi Cancer Institute (RGCI), destined […]
Ethically Correct
National Heart Institute is not owned by an individual, it is a society institute and we need to carry this […]
WHO cites TB threat
World Health Organization and Global Fund cite tuberculosis threat Urgent need for US$ 1.6 billion a year in international […]
OMRON India launches Auto coding and lightweight Blood Glucose Monitor
OMRON Healthcare India, the leader in innovative medical technologies and products for monitoring and therapy, announced the launch of easy-to-use, […]
Stolen health data increasingly sought after for commercial ventures
Hackers generally go after healthcare information they can use in identity theft and other fraud schemes, that data increasingly is […]
India’s first pan India sleep management center launched at Nova Specialty Surgery
Mumbai: Nova Specialty Surgery, a leading chain of short stay medical and surgical centers in India announced the launch of […]
Essential drug makers can no longer quit without informing govt
Pharma companies can no longer quit making essential drugs at will, citing non-viability, without informing the government. Drug makers will […]
When Innovation Meets Care
Rajesh Srivastava, Chairman, Rockland Hospital speaks about technology as an enabler in healthcare. He speaks to Sharmila Das, ENN about […]
On The Growth Trajectory
Vibhu Talwar, COO, Moolchand Medcity, sees Indian healthcare at the threshold of next phase of growth. He shares the hospitals […]
Chinese hackers targeting the healthcare industry
Cyberespionage is gathering momentum and becoming everyday norm. It’s no surprise that the healthcare and medical industry would come up […]
Drug prices continue to remain out of control
The proposed drug pricing policy is riddled with a host of anomalies. Extending price control to all “essential” medicines will […]
Generic sales boost for Ranbaxy
The much awaited US approval for Ranbaxy Laboratories’ generic version of anti-hypertension drug Diovan is likely to come this week, […]
